Moleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
Moleculin Biotech (MBRX) stock took a beating on Wednesday after the clinical-stage pharmaceutical company released results from a Phase 1B/2 study of Annamycin. This study evaluated the safety and effectiveness of Annamycin as a treatment for soft tissue sarcoma lung metastases.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Moleculin Biotech Chairman and CEO Walter Klemp said, 'Looking ahead, we believe these results strongly support further evaluations of Annamycin for the treatment of STS lung mets and we look forward to exploring opportunities to potentially bring this important treatment option to patients.'
While the clinical trial data was positive, it doesn't appear to be as strong as investors hoped. As a result, shares of MBRX stock were down 10.71% as of Wednesday morning. That extends its 55.88% year-to-date drop and 82.82% 12-month decline.
Is Moleculin Biotech Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Moleculin Biotech is Strong Buy, based on three Buy ratings over the past three months. With that comes an average MBRX stock price target of $10.67, representing a potential 1,268.65% upside for the shares.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Quantum stocks higher as Nvidia CEO sees ‘inflection point'
Quantum computing technology is at an inflection point, Nvidia (NVDA) CEO Jensen Huang told the VivaTech conference in Paris on Wednesday, adding that quantum computing will solve 'some interesting problems' in the coming years, Reuters' Supantha Mukherjee reported. The comments sound like a change in tone given that months ago Huang had offered his opinion that 'very useful' quantum computers are likely decades away. Shares of quantum computing stocks moving higher in early Wednesday trading following Huang's comments include D-Wave Quantum (QBTS), IonQ (IONQ), Rigetti Computing (RGTI) and Quantum Computing (QMCO). Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on QBTS: Disclaimer & DisclosureReport an Issue D-Wave enters agreement to sell up to $400M shares from time to time D-Wave Quantum Enters $400M Sales Agreement IBM Announces Plan to Build World's First Large-Scale Quantum Computer Trump Trade: U.S., China representatives to meet about trade D-Wave Quantum's Stock Surges Amid Strategic Moves Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
American Electric to recover $1.5B from insurers
AerCap Holdings has announced that in a judgment the Commercial Court in London found that its subsidiary, AerCap Ireland Limited, is entitled to recover its claim for an indemnity of approximately $1B from the insurers under the 'War and Allied Perils' Coverage section of its contingent and possessed insurance policy. This award is in respect of the aircraft and engines which AerCap and its affiliates formerly leased to Russian airlines and were not recovered from Russia following its invasion of Ukraine in February 2022. The indemnity amount is due to be paid by July 2. All questions of interest and costs are adjourned to a further hearing to be fixed in September. In 2022, the company recognized a pre-tax net charge of $2.7B to earnings, which included a total loss write-off with respect to the assets which remained in Russia and Ukraine and impairment losses with respect to the assets which we had recovered from Russia and Ukraine at that time. Following recoveries of $1.3B in 2023 and $195M in 2024, this indemnity award will bring AerCap's total pre-tax recoveries relating to the Ukraine conflict to approximately $2.5B. The claims against insurers and reinsurers of the Russian airlines' insurance policies in respect of a number of these assets remain ongoing in the Commercial Court in London and we intend to continue to vigorously pursue those claims. However, the collection, timing and amount of any potential further recoveries in respect of those claims are uncertain. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on AEP: Disclaimer & DisclosureReport an Issue American Electric Power Finalizes $2.82 Billion Partnership American Electric price target raised to $100 from $95 at UBS American Electric closes on transmission investment strategic partnership Bloom Energy projects with American Electric, Amazon approved by PUCO PUCO approvals removes regulatory overhang for Bloom Energy, says Morgan Stanley Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Casey's General Stores price target raised to $515 from $450 at BMO Capital
BMO Capital raised the firm's price target on Casey's General Stores (CASY) to $515 from $450 but keeps a Market Perform rating on the shares after its Q4 earnings beat. The company continues to demonstrate meaningful outperformance relative to c-store peers and industry data points, which along with strong execution, has supported its 'impressive consistency' in EBITDA growth, the analyst tells investors in a research note. BMO adds however that the stock's valuation and higher expectations have gone 'from good to great' as it remains on the sidelines for now. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on CASY: Disclaimer & DisclosureReport an Issue Casey's General Stores price target raised to $550 from $500 at KeyBanc Casey's General Stores price target raised to $540 from $460 at Wells Fargo Casey's General Stores Reports Strong Fiscal Year Performance Casey's General Stores Stock (CASY) Jumps 12% on News of Dividend Increase Casey's General Stores reported 'solid' Q4, says RBC Capital Sign in to access your portfolio
